Real-World Patient Characteristics, Treatment Patterns, and Mutation Testing Patterns Among US Patients with Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutations

被引:0
作者
Jinghua He
Christopher D. Pericone
Julie Vanderpoel
机构
[1] Janssen Scientific Affairs,
[2] LLC,undefined
来源
Advances in Therapy | 2022年 / 39卷
关键词
Biomarker testing; mutations; Exon 20 mutations; Immunotherapy; Next-generation sequencing; NSCLC; Treatment pathways; Tyrosine kinase inhibitors;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:3347 / 3360
页数:13
相关论文
共 50 条
[31]   EGFR Mutation Testing in Non-Small Cell Lung Cancer [J].
Sriram, Krishna B. ;
Francis, Santiyagu M. Savarimuthu ;
Tan, Maxine E. ;
Bowman, Rayleen V. ;
Yang, Ian A. ;
Fong, Kwun M. .
CURRENT RESPIRATORY MEDICINE REVIEWS, 2010, 6 (04) :310-321
[32]   Real-world analysis of the prognostic value of EGFR mutation detection in plasma ctDNA from patients with advanced non-small cell lung cancer [J].
Long, Chaolian ;
Li, Kun ;
Liu, Zichen ;
Zhang, Nana ;
Xing, Xuya ;
Xu, Liming ;
Gai, Fei ;
Che, Nanying .
CANCER MEDICINE, 2023, 12 (07) :7982-7991
[33]   Real-world observational study of current treatment patterns and outcomes in recurrent or locally advanced/metastatic non-small cell lung cancer [J].
Bazhenova, Lyudmila ;
Kish, Jonathan ;
Cai, Beilei ;
Caro, Nydia ;
Feinberg, Bruce .
CANCER TREATMENT AND RESEARCH COMMUNICATIONS, 2022, 33
[34]   Treatment Patterns and Survival Outcomes of Non-Small Cell Lung Cancer Patients Initially Diagnosed With Brain Metastases in Real-World Clinical Practice [J].
Chen, Xin-Ru ;
Hou, Xue ;
Dinglin, Xiao-Xiao ;
Liu, Yong-Dong ;
Li, Yin ;
Zheng, Wei ;
Li, De-Lan ;
Chen, Jing ;
Wu, Xiao-Liang ;
Wang, Kai-Cheng ;
Ma, Shu-Xiang ;
Zeng, Yin-Duo ;
Chen, Li-Kun .
FRONTIERS IN ONCOLOGY, 2020, 10
[35]   PD-L1 Testing Patterns and Treatment in Patients With Metastatic Non-Small Cell Lung Cancer in Israel - Analysis of Real-World Data [J].
Apter, L. ;
Moser, S. Sharman ;
Arunachalam, A. ;
Burke, T. ;
Shalev, V. ;
Chodick, G. ;
Siegelmann-Danieli, N. .
JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) :S307-S308
[36]   Clinical outcome of treatment of metastatic non-small cell lung cancer in patients harboring uncommon EGFR mutation [J].
Chantharasamee, J. ;
Poungvarin, N. ;
Danchaivijitr, P. ;
Techawatanawanna, S. .
BMC CANCER, 2019, 19 (1)
[37]   Real-world ALK Testing Trends in Patients With Advanced Non-Small-Cell Lung Cancer in the United States [J].
Lin, Huamao M. ;
Wu, Yanyu ;
Yin, Yu ;
Niu, Huifeng ;
Curran, Eileen A. ;
Lovly, Christine M. ;
Humphries, Michael J. .
CLINICAL LUNG CANCER, 2023, 24 (01) :E39-E49
[38]   Real-World Treatment Patterns, Health Outcomes, and Healthcare Resource Use in Advanced Common EGFR-Positive Non-Small Cell Lung Cancer Patients Treated with Osimertinib in Alberta [J].
Cheung, Winson Y. ;
Carbonell, Chantelle ;
Navani, Vishal ;
Sangha, Randeep S. ;
Ewara, Emmanuel M. ;
Elia-Pacitti, Julia ;
Iczkovitz, Sandra ;
Jarada, Tamer N. ;
Warkentin, Matthew T. .
CURRENT ONCOLOGY, 2024, 31 (08) :4382-4396
[39]   Uptake of novel systemic therapy: Real world patterns among adults with advanced non-small cell lung cancer [J].
Carroll, Nikki M. ;
Eisenstein, Jennifer ;
Burnett-Hartman, Andrea N. ;
Greenlee, Robert T. ;
Honda, Stacey A. ;
Neslund-Dudas, Christine M. ;
Rendle, Katharine A. ;
Vachani, Anil ;
Ritzwoller, Debra P. .
CANCER TREATMENT AND RESEARCH COMMUNICATIONS, 2023, 36
[40]   Study of Gefitinib and Pemetrexed as First-Line Treatment in Patients with Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutation [J].
An, Chaolun ;
Zhang, Jiajun ;
Chu, Hongjun ;
Gu, Chunyan ;
Xiao, Feng ;
Zhu, Fengwei ;
Lu, Rujian ;
Shi, Hai ;
Zhang, Hongfei ;
Yi, Xin .
PATHOLOGY & ONCOLOGY RESEARCH, 2016, 22 (04) :763-768